November 18, & 19, 2009
To sign up for the live webcast, go to http://fdaac.com
FDAAdvisoryCommittee.com
BLA 125324 - H1N1 Discussion
BLA 125285 - Influenza Vaccine
Nov. 18th Agenda: The committee will discuss and make recommendations on the safety and effectiveness of a Pneumococcal 13-valent Conjugate vaccine (Diphtheria CRM197 Protein),BLA 125324, and will hear an update on FDA’s Influenza A (H1N1) 2009 monovalent vaccine activities; Postmarketing surveillance.
Nov. 19th Agenda: The committee will discuss and make recommendations on the safety and effectiveness of an Influenza Vaccine, Purified Recombinant Influenza Hemagglutinin, BLA STN 125285.
To sign up for the live webcast, go to http://fdaac.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment